Oral Cavity Cancer Clinical Trials

42 clinical trials for Oral Cavity Cancer across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery — RECRUITING · NA
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Mandibular Reconstruction Preplanning (ViPMR) — RECRUITING · NA
• Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients — RECRUITING · NA
• Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) — RECRUITING · PHASE2
• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) — RECRUITING · PHASE2
• Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy — RECRUITING · NA
• Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae — RECRUITING · NA
• Radial Forearm Donor Site Closure — RECRUITING · NA
• Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers — RECRUITING · NA
• Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy — RECRUITING
• Immune Biomarker Study for Head and Neck Cancer — RECRUITING
• Screening for Cancers in the Oral CAvity — RECRUITING · NA
• The use of fluorescent tracers in treatment of head and neck cancer — COMPLETED · PHASE2
• Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions — NOT_YET_RECRUITING · PHASE2
• Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors — ACTIVE_NOT_RECRUITING · NA
• Pembrolizumab in Combination With CRT for LA-SCCHN — COMPLETED · PHASE1
• Radiotherapy of Head and Neck Cancer Using an Intraoral Stent — COMPLETED · PHASE2
• Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL — ACTIVE_NOT_RECRUITING · PHASE2
• Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy — ACTIVE_NOT_RECRUITING
• Risk Factors Contributing to Oral Cancer in Patients at Dr. Hasan Sadikin General Hospital Bandung — COMPLETED
• Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis — COMPLETED · PHASE3
• COMBINED CHECKPOINT CO-BLOCKADE IN RESECTABLE ORAL CAVITY AND LARYNX CANCER ¿ A WINDOW OF OPPORTUNITY TRIAL — NOT_YET_RECRUITING
• Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment — NOT_YET_RECRUITING
• Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap Reconstruction — COMPLETED · NA
• A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers — WITHDRAWN · PHASE1
• WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA — OTHER
• CytID Analysis of Oral Lesions — TERMINATED
• Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy — COMPLETED · NA
• Adaptive Radiotherapy for Head and Neck Cancer — COMPLETED · PHASE2
• Cell-free Tumor DNA in Head and Neck Cancer Patients — OTHER · NA
• CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas — COMPLETED · NA
• Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer — COMPLETED
• Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients — COMPLETED · NA
• Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization — OTHER · PHASE2
• SITRAVATINIB (MGCD516) AND NIVOLUMAB IN ORAL CAVITY CANCER WINDOW OPPORTUNITY STUDY (SNOW) — COMPLETED
• Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population — COMPLETED · PHASE3
• Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• Smoking Status and Body Image in Oral Cancer Patients — COMPLETED
• Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment — COMPLETED · PHASE1
• A Study of High-Risk Oral Cavity Cancer — TERMINATED · PHASE2

Refine this search